242 related articles for article (PubMed ID: 32274125)
1. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
[TBL] [Abstract][Full Text] [Related]
2. Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study.
Wang S; Zhang Z; Gu Y; Lv X; Shi X; Liu M
Front Oncol; 2021; 11():726811. PubMed ID: 34956862
[TBL] [Abstract][Full Text] [Related]
3. Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.
Wo Y; Zhao Y; Qiu T; Li S; Wang Y; Lu T; Qin Y; Song G; Miao S; Sun X; Liu A; Kong D; Dong Y; Leng X; Du W; Jiao W
Cancer Med; 2019 Feb; 8(2):669-678. PubMed ID: 30706688
[TBL] [Abstract][Full Text] [Related]
4. Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study.
Ling L; Zheng H; Lin H; Ge C; Li D; Wu L; Lou Y; Jiang T; Fu J
Clin Lung Cancer; 2023 May; 24(3):e141-e151. PubMed ID: 36639280
[TBL] [Abstract][Full Text] [Related]
5. Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size.
Huang W; Deng HY; Lin MY; Xu K; Zhang YX; Yuan C; Zhou Q
Front Oncol; 2022; 12():830470. PubMed ID: 35280762
[TBL] [Abstract][Full Text] [Related]
6. Identifying optimal surgical approach among T1N2-3M0 non-small cell lung cancer patients: a population-based analysis.
Ge T; Hu SQ; Ning J; Zhou YF; Bian DL; Teng MX; Chen LS; Yang J
Transl Lung Cancer Res; 2024 Apr; 13(4):901-929. PubMed ID: 38736488
[TBL] [Abstract][Full Text] [Related]
7. Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer ≤2 cm: A propensity score analysis.
Yin J; Zhao M; Lu T; Huang Y; Sui Q; Xi J; Lin Z; Xu S; Wang Q; Zhan C
J Surg Oncol; 2019 Dec; 120(8):1486-1496. PubMed ID: 31602661
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
9. Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based study.
Zhang T; Zhang JT; Li WF; Lin JT; Liu SY; Yan HH; Yang JJ; Yang XN; Wu YL; Nie Q; Zhong WZ
J Thorac Dis; 2019 Jul; 11(7):2754-2762. PubMed ID: 31463103
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis.
Ma H; Cheng J; Yu Y; Liu B; Qin J; Xing W; Luo S
J Thorac Dis; 2021 Jan; 13(1):312-321. PubMed ID: 33569211
[TBL] [Abstract][Full Text] [Related]
11. Choice of the surgical approach for patients with stage I lung squamous cell carcinoma ≤3 cm.
Chen C; Wang Y; Pan X; Fu S; Shi Y; Yang J; Wang R
J Thorac Dis; 2018 Dec; 10(12):6771-6782. PubMed ID: 30746222
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.
Yang X; Sun F; Chen L; Shi M; Shi Y; Lin Z; Feng M; Zhan C; Jiang W; Wang Q
J Surg Oncol; 2017 Sep; 116(3):398-406. PubMed ID: 28543219
[TBL] [Abstract][Full Text] [Related]
13. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies.
Fan J; Wang L; Jiang GN; Gao W
Ann Surg Oncol; 2012 Feb; 19(2):661-8. PubMed ID: 21769464
[TBL] [Abstract][Full Text] [Related]
14. Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.
Wang L; Ge L; You S; Liu Y; Ren Y
J Cardiothorac Surg; 2022 May; 17(1):110. PubMed ID: 35545793
[TBL] [Abstract][Full Text] [Related]
15. A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer.
Mu JW; Gao SG; Xue Q; Zhao J; Li N; Yang K; Su K; Yuan ZY; He J
Chin Med J (Engl); 2015 Oct; 128(20):2731-5. PubMed ID: 26481738
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of visceral pleural involvement in early-stage lung cancer.
Lakha S; Gomez JE; Flores RM; Wisnivesky JP
Chest; 2014 Dec; 146(6):1619-1626. PubMed ID: 25032521
[TBL] [Abstract][Full Text] [Related]
17. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.
Liu Y; Huang C; Liu H; Chen Y; Li S
World J Surg Oncol; 2014 May; 12():138. PubMed ID: 24886396
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for Stage I nonsmall cell lung cancer: A meta-analysis.
Liu Q; Wang H; Zhou D; Deng X; Min J; Dai J
J Cancer Res Ther; 2016; 12(2):926-31. PubMed ID: 27461676
[TBL] [Abstract][Full Text] [Related]
19. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
Front Oncol; 2021; 11():784289. PubMed ID: 35155190
[TBL] [Abstract][Full Text] [Related]
20. The modification of T description according to visceral pleural invasion and tumor size from 3.1 cm to 4.0 cm in non-small cell lung cancer: A retrospective analysis based on the SEER database.
Qi M; Bian D; Zhang J; Zhu X; Zhou C; Zhang L
Lung Cancer; 2021 Aug; 158():47-54. PubMed ID: 34119932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
